FANCM Connects the Genome Instability Disorders Bloom's Syndrome and Fanconi Anemia

被引:204
|
作者
Deans, Andrew J. [1 ]
West, Stephen C. [1 ]
机构
[1] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, London Res Inst, S Mimms EN6 3LD, Herts, England
基金
英国医学研究理事会;
关键词
COMPLEMENTATION GROUP-M; SYNDROME GENE-PRODUCT; SYNDROME HELICASE; CORE COMPLEX; DNA-REPAIR; RECOMBINATIONAL REPAIR; HOMOLOGOUS RECOMBINATION; REPLICATION FORKS; SYNDROME PROTEIN; PATHWAY;
D O I
10.1016/j.molcel.2009.12.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fanconi Anemia (FA) and Bloom's Syndrome (BS) are genetic disorders characterized by overlapping phenotypes, including aberrant DNA repair and cancer predisposition. Here, we show that the FANCM gene product, FANCM protein, links FA and BS by acting as a protein anchor and bridge that targets key components of the FA and BS pathways to stalled replication forks, thus linking multiple components that are necessary for efficient DNA repair. Two highly conserved protein:protein interaction motifs in FANCM, designated MM1 and MM2, were identified. MM1 interacts with the FA core complex by binding to FANCF, whereas MM2 interacts with RM1 and topoisomerase Ills, components of the BS complex. The MM1 and MM2 motifs were independently required to activate the FA and BS pathways. Moreover, a common phenotype of BS and FA cells-an elevated frequency of sister chromatid exchanges-was due to a loss of interaction of the two complexes through FANCM.
引用
收藏
页码:943 / 953
页数:11
相关论文
共 49 条
  • [31] Fanconi anemia and Aldehyde Degradation Deficiency Syndrome: Metabolism and DNA repair protect the genome and hematopoiesis from endogenous DNA damage
    Mu, Anfeng
    Hira, Asuka
    Mori, Minako
    Okamoto, Yusuke
    Takata, Minoru
    DNA REPAIR, 2023, 130
  • [32] HETEROZYGOUS MANIFESTATIONS IN 4 AUTOSOMAL RECESSIVE HUMAN CANCER-PRONE SYNDROMES - ATAXIA TELANGIECTASIA, XERODERMA-PIGMENTOSUM, FANCONI ANEMIA, AND BLOOM SYNDROME
    HEIM, RA
    LENCH, NJ
    SWIFT, M
    MUTATION RESEARCH, 1992, 284 (01): : 25 - 36
  • [33] Malformative syndrome and serum alpha-fetoprotein level are predictors of the hematological outcome in Fanconi's anemia patients
    Guardiola, P
    Cassinat, B
    Chadelat, C
    Soulier, J
    Leblanc, T
    Larghero, J
    Socie, G
    Schlageter, MH
    Gluckman, E
    BONE MARROW TRANSPLANTATION, 2003, 31 : S262 - S262
  • [34] Induction of a hematological and cytogenetic remission in a patient with a myelodysplastic syndrome secondary to Fanconi's anemia employing the S-HAM regimen
    W. Verbeek
    D. Haase
    C. Schoch
    W. Hiddemann
    B. Wörmann
    Annals of Hematology, 1997, 74 : 275 - 277
  • [35] Induction of a hematological and cytogenetic remission in a patient with a myelodysplastic syndrome secondary to Fanconi's anemia employing the S-HAM regimen
    Verbeek, W
    Haase, D
    Schoch, C
    Hiddemann, W
    Wormann, B
    ANNALS OF HEMATOLOGY, 1997, 74 (06) : 275 - 277
  • [36] Genome-wide phenotype analysis in ES cells by regulated disruption of Bloom's syndrome gene
    Yusa, K
    Horie, K
    Kondoh, G
    Kouno, M
    Maeda, Y
    Kinoshita, T
    Takeda, J
    NATURE, 2004, 429 (6994) : 896 - 899
  • [37] BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity
    Yin, JH
    Sobeck, A
    Xu, C
    Meetei, AR
    Hoatlin, M
    Li, L
    Wang, WD
    EMBO JOURNAL, 2005, 24 (07): : 1465 - 1476
  • [38] Genome-wide phenotype analysis in ES cells by regulated disruption of Bloom's syndrome gene
    Kosuke Yusa
    Kyoji Horie
    Gen Kondoh
    Michiyoshi Kouno
    Yusuke Maeda
    Taroh Kinoshita
    Junji Takeda
    Nature, 2004, 429 : 896 - 899
  • [39] Abnormal telomere metabolism in Fanconi's anemia correlates with the genomic instability and with the severity of the disease. Implication for a biological prognostic scoring system.
    Li, X
    Leteurtre, F
    Berger, R
    Noguera, M
    Maarek, O
    Gluckman, E
    BLOOD, 1999, 94 (10) : 410A - 410A
  • [40] Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and bloom syndrome mutations in Ashkenazi Jewish population: Possible role in risk modification for cancer development
    Koren-Michowitz, M
    Friedman, E
    Gershoni-Baruch, R
    Brok-Simoni, F
    Patael, Y
    Rechavi, G
    Amariglio, N
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (03) : 203 - 206